|
Volumn 12, Issue 4, 2003, Pages 329-334
|
Stem cell therapies in reparative medicine
|
Author keywords
Alpha 1 antitrypsin; Development; Diabetes; Human embryonic stem cells; Mesenchymal stem cells
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
ALLOIMMUNITY;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
AUTOIMMUNITY;
BAHAMAS;
CELL FATE;
CELL PROLIFERATION;
CLINICAL FEATURE;
CONFERENCE PAPER;
DEVELOPMENTAL BIOLOGY;
ENRICHMENT CULTURE;
FUTUROLOGY;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
IMMUNOLOGY;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
PROBLEM SOLVING;
RECURRENCE RISK;
SHIPPING;
STEM CELL TRANSPLANTATION;
TECHNOLOGY;
TISSUE ENGINEERING;
TREATMENT PLANNING;
UNITED STATES;
|
EID: 0041707890
PISSN: 09636897
EISSN: None
Source Type: Journal
DOI: 10.3727/000000003108746849 Document Type: Conference Paper |
Times cited : (9)
|
References (7)
|